Landscapes / Targets

DNA

17 drugs act on DNA, in 26 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs17

DrugHow it worksCompanyStageNext dateDetails
—
Approved Dec 2026Phase 2 trial completes
Triazaacenaphthylene bacterial type II topoisomerase inhibitor
Approved 17 May 2027Phase 1 trial completes
Alkylating drug
Approved 31 Dec 2027Phase 3 trial completes
—
Phase 3 31 Jan 2027Phase 2 trial completes
SyB V-1901not checked
—
Phase 3 31 Jan 2028Phase 3 trial completes
Zimoxinnot checked
—
Phase 2/3 Oct 2030Phase 2/3 trial completes
—
Phase 1/2 31 Dec 2027Phase 1/2 trial completes
—
Phase 1/2 30 Jun 2028Phase 1/2 trial completes
—
Novartis · Public NVS
Phase 1/2 10 Jul 2028Phase 1/2 trial completes
—
Phase 2 31 Aug 2028Phase 2 trial completes
Methoxsalennot checked
Photoactivated radical Generator; psoralen
Phase 2 Dec 2028Phase 2 trial completes
—
Phase 1/2 —
—
Phase 1/2 —
—
Phase 1 30 Dec 2026Phase 1 trial completes
—
Phase 1 31 May 2027Phase 1 trial completes
—
Phase 1 30 Nov 2028Phase 1 trial completes
—
Phase 1 —

About this list

Checked
13 of 17 drugs. The other 4 are marked “not checked” in the list. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow DNA

Following is part of Solo: you see every change to DNA the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in